Opinion

Video

CONTACT-03: Atezolizumab Plus Cabozantinib in Advanced RCC

Experts on advanced RCC discuss the CONTACT-03 trial evaluating atezolizumab plus cabozantinib following immune checkpoint inhibitor treatment in patients with inoperable disease.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected

    Newsletter

    Stay up to date on the most recent and practice-changing oncology data